Study for children with strep throat using beta-lactam antibiotics
Part of Ear, nose & throat, Infections clinical trials.
This study looks at children ages 5–15 who test positive for Group A strep (often called strep throat). It may help by testing an antibiotic approach with beta-lactam medicines for children who are expected to need treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 5 to 15 years old
- Have a rapid test that is positive for Group A strep
- Have a parent or legal guardian who can give consent
- Your clinician plans to treat you with a beta-lactam antibiotic
- Be able to take beta-lactam antibiotics safely
- Have no other bacterial infection at the same time (like pneumonia)
- Speak English (or be able to complete the study in English)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people under 18 who have a confirmed invasive Group A strep infection, meaning strep bacteria found in places that are normally sterile (like the blood or deep tissues). It tests whether a specific study approach can help improve outcomes for children with these serious infections.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
This study collects information from parents about newborns who had an invasive Group B Strep infection around the time of birth. It aims to better understand the long-term effects of this infection.
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
This trial looks at whether phenoxymethylpenicillin (an antibiotic) helps people with a certain type of sore throat more than not using antibiotics. You may qualify if your symptoms match a likely bacterial cause and a rapid test for strep is negative.
This study looks back at cases of a rare bacterial infection called Streptobacillus moniliformis in France between 2007 and 2023. It aims to better understand how the infection affects people of all ages.
Hear when a new Streptococcal Pharyngitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.